dt 5461 has been researched along with picibanil in 1 studies
| Studies (dt 5461) | Trials (dt 5461) | Recent Studies (post-2010) (dt 5461) | Studies (picibanil) | Trials (picibanil) | Recent Studies (post-2010) (picibanil) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 1,602 | 149 | 143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumazawa, E; Kusama, T; Osada, Y; Soga, T; Tohgo, A | 1 |
1 other study(ies) available for dt 5461 and picibanil
| Article | Year |
|---|---|
Significant antitumor effect of a synthetic lipid A analogue, DT-5461, on murine syngeneic tumor models.
Topics: Animals; Antineoplastic Agents; Ascites; Bone Marrow; Disaccharides; Lipid A; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Picibanil; Tumor Cells, Cultured | 1992 |